400-921-8278
| Catalog_no | ADMC0320 |
| Product_name | Cebranopadol(GRT-6005) |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 3740.00/10060.00/18120.00 |
| Specificity | Target: Opioid Receptor. Fields: branopadol(GRT-6005) is a novel first in class compounds with potent agonist activity on ORL-1 (opioid receptor like -1) and the well established mu opioid receptor. EC50: 13±2 nM (hNOP receptor), 1.2±0.4 nM (hMOP re |
| Dilution | EC50: 13±2 nM (hNOP receptor), 1.2±0.4 nM (hMOP receptor), 17±5 nM (hKOP receptor), 110±28 nM (hDOP receptor)[1] |
| Purification | >98% |
| Concentration | 靶点：Opioid Receptor;IC50：EC50: 13±2 nM (hNOP receptor), 1.2±0.4 nM (hMOP receptor), 17±5 nM (hKOP receptor), 110±28 nM (hDOP receptor)[1] |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername | GRT-6005; GRT 6005; GRT6005 |
| Observed_band | 378.48 |
| Notes | branopadol(GRT-6005) is a novel first in class compounds with potent agonist activity on ORL-1 (opioid receptor like -1) and the well established mu opioid receptor. EC50: 13±2 nM (hNOP receptor), 1.2±0.4 nM (hMOP receptor), 17±5 nM (hKOP receptor), |
| Instructions | 
查看与下载 |
| Share |
 |
Copyright © 2021 苏州博特龙免疫技术有限公司 版权所有 ，苏ICP备2021013855号-1
苏公网安备32050702011981号 
